HTR2B作为慢性阻塞性肺病的新生物标志物,具有肺状细胞癌

Yue Li1, Yu Wang1, Ruhao Wu1

  • 1Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.

Scientific reports
|June 8, 2024
PubMed
概括

这项研究确定了HTR2B作为慢性阻塞性肺病 (COPD) 和肺状细胞癌 (LUSC) 的潜在生物标志物和治疗标. 升调HTR2B与慢性肺炎,上皮层-介质细胞过渡和LUSC进展有关.